Updated:
Cochlear Limited
Cochlear is a leader in hearing device implants that help to restore hearing and connect people to a world of sound. Start your hearing journey today!
Cochlear Limited
Cochlear is a leader in hearing device implants that help to restore hearing and connect people to a world of sound. Start your hearing journey today!
General information
Firm type
other
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Additional offices
San Francisco, CA · New York, NY · Minneapolis, MN
Sector focus
Frequently asked questions
What products does Cochlear Americas sell?
Cochlear Americas markets three main product lines: the Nucleus cochlear implant system (including the new smart Nucleus Nexa), the Osia bone conduction implant system, and the Baha sound processors. These are surgically implanted hearing devices.
Does Cochlear Americas disclose financials like AUM or revenue?
No. As a subsidiary, Cochlear Americas does not publish separate financial data. Global results are reported by the Australian parent company Cochlear Limited on the ASX.
What is the most recent product launch from Cochlear Americas?
The company highlights the Cochlear Nucleus Nexa System as the world's first smart cochlear implant system. The exact launch date is not specified on the site.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: